Search

Ocugen Inc

Cerrado

1.02 2

Resumen

Variación precio

24h

Actual

Mínimo

0.97

Máximo

1

Métricas clave

By Trading Economics

Ingresos

-5.7M

-25M

Ventas

-45K

1.5M

BPA

-0.07

Margen de beneficios

-1,671.841

Empleados

116

EBITDA

-2.5M

-20M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+919.64% upside

Dividendos

By Acuity

Próximas Ganancias

4 nov 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-57M

359M

Apertura anterior

-0.98

Cierre anterior

1.02

Ocugen Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

16 sept 2026, 23:56 UTC

Correlated Moves

EnerSys is trading higher in after-market hours, reflecting broader gains in the Nasdaq 100 Index following the Federal Reserve's rate hike decision.

16 sept 2026, 23:56 UTC

Atomera Inc is trading modestly lower in after-hours activity, retracing from a peak shortly after the market closed on Wednesday.

16 sept 2026, 23:56 UTC

Correlated Moves

Axcelis Technologies Inc is trading modestly higher in after-market hours, influenced by a broader upward trend in the Nasdaq 100 Index following the Fed's rate hike.

16 sept 2026, 23:56 UTC

Reliance Inc is trading slightly lower in after-market hours, continuing a downward trend since Wednesday's close and fluctuating near the lower end of its one-month range.

16 sept 2026, 23:56 UTC

Correlated Moves

Rockwell Automation Inc is trading slightly higher in after-market hours following the Federal Reserve's 25 basis point rate hike amid inflation concerns.

16 sept 2026, 23:56 UTC

Norfolk Southern Corp's shares declined in after-market trading, moving lower from a post-close high and indicating unusual weakness for this time of day.

16 sept 2026, 23:56 UTC

Correlated Moves
News

Cohu Inc's stock rose during after-market hours, buoyed by a slight increase in the Nasdaq 100 Index amid macroeconomic developments and ongoing governance discussions.

16 sept 2026, 23:56 UTC

Correlated Moves

Columbia Financial Inc declined in after-market trading, influenced by NBT Bancorp Inc's slight decrease, settling below its previous close.

16 sept 2026, 23:56 UTC

Correlated Moves

SkyWest Inc's shares are roughly flat in after-market trading, stabilizing near unchanged levels following earlier losses and aligning with routine trading patterns.

16 sept 2026, 23:56 UTC

Correlated Moves

FormFactor Inc is trading higher in after-market hours, reflecting gains in the Nasdaq 100 Index following the Federal Reserve's rate hike decision.

16 sept 2026, 23:56 UTC

UGI Corp is declining in after-market trading, positioned near its lowest cumulative return for the day after a brief recovery earlier in the session.

16 sept 2026, 23:56 UTC

BJ's Restaurants Inc. is trading slightly lower in after-market hours, finishing down for three consecutive sessions and remaining below its 20-day moving average.

16 sept 2026, 23:56 UTC

New Fortress Energy Inc gained in after-market trading on Wednesday, rebounding from earlier session lows after a month of underperformance.

16 sept 2026, 23:56 UTC

Waste Management Inc. is trading modestly higher in after-market hours following a slight decline since Wednesday's close, remaining below its 20-day moving average.

16 sept 2026, 23:56 UTC

News

T-Mobile US Inc appointed Jessica Uhl as CFO Designate, succeeding Peter Osvaldik, as the stock remained roughly flat in after-market trading.

16 sept 2026, 23:56 UTC

Macro News

The U.S. Federal Reserve raised interest rates by a quarter-point, impacting energy markets, while natural gas prices remain roughly flat today.

16 sept 2026, 23:56 UTC

TG Therapeutics Inc is trading lower in after-market hours, retracing from an initial high shortly after the market closed, despite remaining above its 20-day moving average.

16 sept 2026, 23:52 UTC

MannKind Corp is seeing higher after-market trading, reflecting broader market gains despite concerns over TIC outflows and rising Treasury yields.

16 sept 2026, 23:52 UTC

General Motors Co is trading modestly lower in after-market hours, remaining below its 20-day moving average after a recent trend of lower daily closes.

16 sept 2026, 23:52 UTC

Correlated Moves

Corning Inc is advancing in after-market trading, supported by positive retail sales data and broader market trends, despite a $27.9B outflow in TIC flows.

16 sept 2026, 23:51 UTC

Correlated Moves

Chimera Investment Corp is trading modestly higher in after-market hours, potentially influenced by AGNC's inclusion in the S&P MidCap 400 Index.

16 sept 2026, 23:51 UTC

Correlated Moves
News
Social Media

NVIDIA shares rose in after-market trading as CEO Jensen Huang discussed AI safety at Dreamforce, coinciding with Salesforce's Koa CRM model announcement.

16 sept 2026, 23:51 UTC

Viavi Solutions Inc is trading higher in after-market hours, following strong U.S. retail sales data, despite concerns over TIC flows and rising Treasury yields.

16 sept 2026, 23:51 UTC

Dolby Laboratories Inc is rising in after-market trading, supported by stronger-than-expected U.S. retail sales data, despite concerns over $27.9B in TIC outflows.

16 sept 2026, 23:51 UTC

Ironwood Pharmaceuticals Inc is trading modestly lower in after-market hours, positioned below its 20-day moving average and around the midpoint of its one-month trading range.

16 sept 2026, 23:51 UTC

Correlated Moves

Northern Oil and Gas Inc is trading modestly higher in after-market hours, following strong August retail sales data that exceeded forecasts.

16 sept 2026, 23:51 UTC

Social Media
News

Alphabet Inc. will not be required to break up its ad tech unit, and GOOGL shares rose in after-market trading following a $22B chip loan report and an analyst price target increase.

16 sept 2026, 23:51 UTC

Rapid7 Inc is higher in after-market trading, supported by stronger-than-expected U.S. retail sales data, despite some negative sentiment from TIC flows.

16 sept 2026, 23:51 UTC

Canadian Solar Inc is advancing in after-market hours, supported by strong U.S. retail sales for August, despite disappointing net long-term TIC flows.

16 sept 2026, 23:51 UTC

Blue Owl Capital Corp is trading modestly higher in after-market hours, showing a recovery from earlier lows but remains near the lower end of its one-month range.

Comparación entre iguales

Cambio de precio

Ocugen Inc previsión

Precio Objetivo

By TipRanks

919.64% repunte

Estimación a 12 Meses

Media 10.125 USD  919.64%

Máximo 12 USD

Mínimo 8 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Ocugen Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

4 ratings

4

Comprar

0

Mantener

0

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Ocugen Inc

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve patients' health. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis; OCU410, a gene therapy under phase 1/2 for the treatment of dry age-related macular degeneration (AMD); and OCU410ST, a gene therapy under phase 1/2 for the treatment of Stargardt disease. It is also involved in the development of OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet age-related macular degeneration; and NeoCart, an autologous chondrocyte-derived neocartilage, currently under Phase 3 studies indicated for the repair of knee cartilage injuries in adult. In addition, the company is developing OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine. It has collaboration agreements with National Institute of Allergy and Infectious Diseases for early clinical studies for the OCU500 program; and a strategic partnership with CanSino Biologics Inc. for manufacturing its modifier gene therapy pipeline product candidates. The company was founded in 2013 and is headquartered in Malvern, Pennsylvania.
help-icon Live chat